Clinical trial · Observational
Self-Collected Swabs for Primary Human Papilloma Virus (HPV) Screening
Self-Collected Swabs for Primary Primary Human Papilloma Virus (HPV) Screening
NCT05989464CI-TRIAL-00069090unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, the investigators will assess whether implementing a self-swab protocol for primary Human Papilloma Virus (HPV) testing is an effective method to increase cervical cancer screening in a sample of unscreened women in Hawaii. The findings of this study may support adoption of HPV self swab protocols both at Kalihi Palama Health Center (KPHC) and other Federally Qualified Health Centers (FQHC) in Hawaii.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HPV | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Self-swab for genital HPV | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Human Papilloma Virus (HPV) Self swab
- description
- Enrolled participants will be instructed to perform a self swab for genital Human Papilloma Virus (HPV) infection. Additionally, a short survey will be administered to collect demographic information, evaluate knowledge of HPV/cervical cancer, and assess acceptability of HPV self swab.
- interventionNames
- Diagnostic Test: Self-swab for genital HPV
Primary outcomes (2)
- measure
- Percentage of swabs with result
- timeFrame
- Within 1 week of swab collection
- description
- Percentage of swabs with result
- measure
- Percentage of participants with abnormal result
- timeFrame
- Within 1 week of swab collection
- description
- Percentage of participants with abnormal result
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Age of 25 years or older * Have a cervix * Have an indication for cervical cancer screening per Accreditation Council for Continuing Medical Education (ASCCP) guidelines * Have been previously referred to women's health in the past 5 years or subjects have declined a women's health referral. * Subjects must not have been seen in women's health clinic since referral was placed Exclusion Criteria: * Subjects unable to consent in one of the following languages: English, Chuukese, or Marshallese * Subjects with known history of cervical cancer * Subjects that are currently pregnant or within 3 months of giving birth
References
Publications (0)
Data not yet available
No reference posted for this study.